VRTX - Vertex Pharmaceuticals Incorporated
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$560.92
DETAILS
HIGH:
$665.00
LOW:
$350.00
MEDIAN:
$580.00
CONSENSUS:
$560.92
UPSIDE:
2.71%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Greenblatt | 18,986 | $9.4M | 0.0% | -1,901 | DECREASED |
| Dalio | 10,865 | $5.4M | 0.0% | -2,492 | DECREASED |
| Cooperman | 3,105 | $1.5M | 0.0% | -245,855 | DECREASED |
| Wood | 1,600 | $794,768 | 0.0% | -2,000 | DECREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-08-28 | Ambrose Kristen | officer: SVP & Chief Accounting Officer | A-Award | 5,000 | -- | -- |
| 2026-08-27 | SACHS BRUCE I | director | G-Gift | 6,000 | -- | -- |
| 2026-07-21 | Tatsis Ourania | officer: EVP, Chief Reg. & Quality Off. | A-Award | 8,251 | -- | -- |
| 2026-07-21 | Sachdev Amit | officer: EVP Chief Patient & Ext Af Off | A-Award | 8,251 | -- | -- |
| 2026-07-15 | SACHS BRUCE I | director | A-Award | 99 | -- | -- |
| 2026-07-15 | Garber Alan M | director | A-Award | 31 | -- | -- |
| 2026-07-02 | Tatsis Ourania | officer: EVP, Chief Reg. & Quality Off. | SELL | 1,500 | $524.99 | $787K |
| 2026-07-02 | McKechnie Duncan | officer: EVP, Chief Commercial Officer | SELL | 1,541 | $519.00 | $800K |
| 2026-07-01 | Liu Joy | officer: EVP and Chief Legal Officer | SELL | 828 | $502.71 | $416K |
| 2026-06-26 | Bozic Carmen | officer: EVP and CMO | SELL | 596 | $482.50 | $288K |
| 2026-06-18 | Bozic Carmen | officer: EVP and CMO | SELL | 1,020 | $462.17 | $471K |
| 2026-06-15 | Bozic Carmen | officer: EVP and CMO | SELL | 4,062 | $450.00 | $1.8M |
| 2026-06-05 | Bozic Carmen | officer: EVP and CMO | SELL | 1,745 | $450.00 | $785K |
| 2026-05-29 | Bozic Carmen | officer: EVP and CMO | SELL | 1,974 | $450.00 | $888K |
| 2026-05-15 | Bunnage Mark E. | officer: EVP, Chief Scientific Officer | SELL | 33 | $453.45 | $15K |
| 2026-05-15 | Bozic Carmen | officer: EVP and CMO | SELL | 1,354 | $453.45 | $614K |
| 2026-05-12 | Bozic Carmen | officer: EVP and CMO | SELL | 6,988 | $450.00 | $3.1M |
| 2026-05-01 | Garber Alan M | director | A-Award | 472 | -- | -- |
| 2026-05-01 | Schneider Jennifer | director | D-Return | 796 | -- | -- |
| 2026-05-01 | MCKENZIE DIANA | director | A-Award | 796 | -- | -- |
| 2026-05-01 | Lagarde Michel | director | A-Award | 2,866 | $424.45 | $1.2M |
| 2026-05-01 | Bhatia Sangeeta N. | director | A-Award | 943 | -- | -- |
| 2026-05-01 | Thornberry Nancy | director | A-Award | 1,433 | $424.45 | $608K |
| 2026-05-01 | Thornberry Nancy | director | D-Return | 398 | -- | -- |
| 2026-05-01 | Liu Joy | officer: EVP and Chief Legal Officer | SELL | 1,104 | $425.02 | $469K |
Congressional Trading
| DATE | MEMBER | CHAMBER | TYPE | AMOUNT |
|---|---|---|---|---|
| 2026-07-21 | Alan Armstrong | SENATE | Purchase | $1,001 - $15,000 |
| 2026-05-13 | Ro Khanna | HOUSE | Purchase | $1,001 - $15,000 |